Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
about
Clinical immunologic approaches for the treatment of Alzheimer's diseaseAntenatal interventions for fetomaternal alloimmune thrombocytopeniaAntenatal interventions for fetomaternal alloimmune thrombocytopeniaModulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functionsImmune complexes as therapy for autoimmunityMonoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterizationComplement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibodyThe antiinflammatory activity of IgG: the intravenous IgG paradoxMyasthenia gravis: past, present, and futureK/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory ArthritisThe Production Processes and Biological Effects of Intravenous ImmunoglobulinIntravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory DermatosesInduction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate ImmunityFc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesTreatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectivesIntravenous immunoglobulin and Alzheimer's disease: what now?Targeting the Fc receptor in autoimmune diseaseIgG placental transfer in healthy and pathological pregnanciesPrevention and treatment in utero of autoimmune-associated congenital heart blockStructural Characterization of Anti-Inflammatory Immunoglobulin G Fc ProteinsAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesDengue: an update on treatment optionsTumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesThe pathogenesis of immune thrombocytopaenic purpuraB cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice.Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1.Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applicationsIVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity.Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.Treatment with megestrol acetate improves human immunodeficiency virus-associated immune thrombocytopeniaAnti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcgammaR) reactive reagents.Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study.Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy.
P2860
Q22241380-F83BA79E-6996-454D-93B6-CB6177FE8AFEQ24234535-AD5CE0B7-F0A3-45F4-886B-0EF69809C5B1Q24245104-D00F8E17-B41C-4297-9082-A8869991B45EQ24532019-0E50EDC3-5A27-4EA6-8B25-FA08B7BEAEF8Q24532135-19F9BC15-8EBF-49B3-BCAA-1EACFD40A41FQ24558642-CD01DD9E-88C0-4DD0-BE95-817984DEC477Q24655389-83485C5E-6F7C-4D10-BF21-E776A1E0F74DQ24674255-69F6263F-F62E-4319-8941-D86BE550D2B8Q24676548-88EC1814-348F-4600-AE96-CE84B30CDF34Q24678531-896E7638-56FE-4C45-985A-1DFBEFDB28ACQ26745541-9EF3F4C5-7055-4123-AC66-37A014E90E01Q26752540-993932BA-AB5C-4492-AAA5-50760EC2B3A0Q26765226-98EE9555-CB3A-44B9-9C44-988A063EA75BQ26781290-EA89F757-8E6B-42AF-BD4E-76379678BD07Q26783175-B7DEB26A-3794-43E3-8BFD-984867943A3EQ26822442-A7CC58E2-AB40-4A40-A178-65E0B4DF525DQ27000371-3E29BE82-EE55-4F46-80A9-638193335DB2Q27002843-423BDA36-F508-40E1-8BDB-22DD5BDD7F21Q27025979-A4B6E6A7-36EF-40ED-A167-1DC53DCD19E9Q27026699-ABB1F501-1BB3-4372-B97F-70151861EEB3Q27684721-D10DE3F0-893E-42B2-8E3F-C61B9CE3CF6AQ27687250-CB3CED8A-EDED-468D-BD14-03FAEFEED9BDQ28069362-BFDF17B7-5648-4E07-BC83-90833EA96EE0Q28085044-2508B12E-EB0F-480C-BED4-758AF63EA54DQ28219857-7814C818-8C9A-4D5A-BD90-57490855C5E9Q28236898-42590079-B0E5-48D2-8C9A-D0ED2DB78485Q30490538-F98D8746-0446-4FCC-9EE1-5EA262084769Q30514056-F36CFA2F-19DB-43D8-8ED5-216B12CFD987Q30834514-85DCA6B8-A055-4082-880B-9DA39234B594Q33340127-90A0CB6B-65FD-4E75-90AA-995BB185C084Q33341449-44B00900-FFA3-43F9-8E6A-EB3C14858C95Q33342250-87E5D691-40AB-4DAE-B736-D52840A2B0BAQ33346489-D880F7C2-8834-42D0-B780-1FAA6F5D5EEDQ33359732-5791A465-63DE-4AC1-B644-30E2F20FEB52Q33359740-ECAB4E3E-2DE3-4F0E-90DB-1D62D1990A78Q33362763-1EBD8120-AA9E-479F-AF68-9221874D7823Q33363853-314F4748-1C8C-41AF-A54B-D8AAFCD6B394Q33364381-FB24B865-5AC4-4716-89F9-D46BA7CC80AEQ33364630-B9C5A7DF-7B43-4E82-9949-503B88A21832Q33369379-F302C496-0C49-40DF-9E22-0EF6179DCBA1
P2860
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@ast
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@en
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@nl
type
label
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@ast
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@en
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@nl
prefLabel
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@ast
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@en
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@nl
P2093
P1433
P1476
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
@en
P2093
A Samuelsson
J V Ravetch
T L Towers
P304
P356
10.1126/SCIENCE.291.5503.484
P407
P577
2001-01-01T00:00:00Z